Opendata, web and dolomites

T-CONTROL

Novel catheter to reduce Urinary Tract Infections (UTIs)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 T-CONTROL project word cloud

Explore the words cloud of the T-CONTROL project. It provides you a very rough idea of what is the project "T-CONTROL" about.

uc    million    weak    linked    foreseeing    approval    develops    ipr    assessing       safety    retention    interventions    competition    waste    thanks    sheets    16    14    14b    guarantee    conclude    bags    pave    injury    mainly    raised    commercializing    letters    feasibility    quality    reduce    spinal    unmet    infection    frequently    route    bn    continence    investment    urine    catheter    professionals    customers    substentially    plan    incontinence    gloves    life    events    nursing    membrane    business    patients    risk    solutions    hypertrophy    representing    eur    mentioned    special    hydrophobic    alone    decline    material    prescribers    decreasing    savings    patent    workers    frequent    investments    innovative    ratification    difference    previously    hospitalization    sme    medical    catheters    sharp    days    market    revenues    acute    deaths    urinary    prostate    care    direct    custom    financial    stage    sl    made    indwelling    channels    rethink    stakeholders    muscle    diapers    cord    introduction    29    health    hospitals    visits    treatment    emergency    causing    additional   

Project "T-CONTROL" data sheet

The following table provides information about the project.

Coordinator
RETHINK MEDICAL SL 

Organization address
address: C/ PRACTICANTE IGNACIO RODRIGUEZ S/N - EDIFICIO PO II DEL CAMPUS UNIVERSITARIO DE TAFIRA
city: LAS PALMAS DE GRAN CANARIA
postcode: 35017
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.rethinkmedical.es
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RETHINK MEDICAL SL ES (LAS PALMAS DE GRAN CANARIA) coordinator 50˙000.00

Map

 Project objective

T-Control is an innovative indwelling urinary catheter. Urinary Catheters (UC) are one of the most frequently used medical devices on the market. They are used during medical interventions and treatment, as well as incontinence or urine retention in case of spinal cord injury, prostate hypertrophy, weak muscle, and many other conditions.

There are several unmet needs related to currently used catheters. They cause a sharp decline of quality of life of the patients, are linked to frequent emergency visits and increase substentially the risk of infection both for patients and health care professionals. There are about 1,3 million cases in EU, causing 1,8 bn EUR direct cost and more than 14,000 deaths.

T-Control is addressing all the previously mentioned problems thanks to its novel design and a special hydrophobic membrane material, with patent approval both in EU and US, developed after 4 years of R&D.

T-Control will reduce additional days of hospitalization (leading to €1.14B savings in EU alone), but also guarantee the safety of health workers and decreasing continence related waste (sheets, gloves, diapers, catheters, bags…) representing around 29% of medical waste in non-acute hospitals.

Rethink Medical SL develops new medical solutions, mainly linked to nursing. It raised the interest of 16 stakeholders on the market (Letters of Support).

The feasibility study (SME Phase 1) shall address a financial plan, foreseeing all the costs and investments associated with commercializing our custom-made UC and the expected revenues. The study will also aim at assessing other important aspects such as IPR management, determine the best investment route for the growth stage, and conclude the best channels to reach customers and how we can best explain our difference from competition (prescribers, events, hospitals…). All these activities will lead to the ratification of a detailed business plan that will pave the way towards an effective market introduction.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "T-CONTROL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "T-CONTROL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

CyreenApplication (2019)

Connecting Ad-Impressions with Purchase. The new advanced Advertisement at the point of sales.

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More